ArticlePoultry science2026
Integrative multi-omics analyses reveal the molecular mechanisms of lysozyme in alleviating hepatic lipid accumulation in post-peak laying quail.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lysozyme is a natural antimicrobial protein increasingly used as an antibiotic alternative in animal husbandry. However, its role in hepatic lipid metabolism, especially in post-peak laying poultry, is not well understood. This study employed a multi-omics approach to investigate the hepatic responses in late-laying quails supplemented with lysozyme (500 mg/kg diet) for 8 weeks compared to a control group. Lysozyme supplementation significantly increased average egg weight during week 1∼4 (P < 0.01). At the end of the trial, it significantly reduced hepatic lipid droplet area and triglyceride content (P < 0.05). Multi-omics analysis revealed that these improvements were linked to a coordinated alleviation of endoplasmic reticulum (ER) stress and reductions in lipotoxic metabolites, despite no observed effects on gut morphology. Specifically, lysozyme downregulated key ER stress-related genes, including protein kinase R-like endoplasmic reticulum kinase (PERK), eukaryotic translation initiation factor 2 alpha (EIF2α), and activating transcription factor 4 (ATF4) (P < 0.05), as well as lipogenic genes such as fatty acid synthase (FASN) and acetyl-CoA carboxylase 1 (ACC1) (P < 0.01). It also decreased hepatic sphingoid bases and saturated fatty acids (P < 0.05), contributing to reduced lipogenesis and hepatocyte apoptosis (P < 0.05). Although 16S rRNA sequencing revealed no shifts in overall α- or β-diversity, lysozyme induced specific taxa changes which characterized by increasedabundances of Bacteroides gallinaceum and Olsenella spp., alongside reduced levels of Subdoligranulum and RF39-related bacteria. Mantel correlation analysis further indicated species-specific associations between these microbial changes and host ER stress and lipid metabolism parameters, implicating gut microbiota-mediated modulation of hepatic responses. In summary, these findings demonstrate that dietary lysozyme mitigates hepatic steatosis in post-peak laying quails through coordinated suppression of ER stress and lipogenesis, alongside concurrent specific gut microbial alteration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.